Augmedics, a US-based surgical image guidance technology developer using augmented reality, has raised $36m in its series C financing from a consortium including Hospital Corporation of America’s (HCA) corporate venturing unit.
Alongside HCA Healthcare’s Health Insight Capital and VC firm XR Invest (formerly known as AO Invest) in the round were lead investors, private equity firms HIG Capital, Revival Healthcare Capital, and Tel Aviv-listed Almeda Ventures.
This round only eight months after the company closed its $21m B financing, bringing the total funding to date to $63m.
In December 2019, Augmedics said US authorities cleared its Xvision Spine System (XVS) to let surgeons visualise the 3D spinal anatomy of a patient during surgery and last year saw 250 spinal surgeries performed with the system. The money will be used to obtain CE certification for sales in Europe.
New Harbor Venture Partners acted as advisers to Augmedics.
